5295 Westview Drive, Suite 275
Tel: +1 301-200-5366
About RoosterBio, Inc.
RoosterBio is a leading supplier of adult human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems designed to rapidly accelerate the commercialization of scalable regenerative cures. We have simplified and standardized how high- volume, affordable hMSCs and hMSC-derived extracellular vesicles (EVs) are purchased, expanded, and used in product development. Our translation-friendly products are well-characterized and paired with highly engineered media systems. This leads to marked time and cost savings for customers and rapid integration into product development. RoosterBio accelerates the clinical translation of cell therapies and tissue engineering technologies, shortens the time to market of such technologies, and ultimately benefits healthcare providers and their patients. We seek to democratize cell culture for the masses and are driving the transition of MSCs from a scarce resource into an abundant one. Follow us on social media and our website, where we help to educate people on industry trends, cell culture, and scientific developments in general.
2 articles with RoosterBio, Inc.
RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the ClinicCollaboration leverages cGMP clinical hMSC systems to accelerate gene modified cell therapy for solid tumors.
RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to accelerate the clinical translation of Senti’s gene-modified cell therapies for ovarian cancer and other solid tumor indications. The collaboration will leverage RoosterBio’s human mesenchymal stem/stromal cell (hMSC) bioprocess systems, rapid product and process development platform, and
The start of 2020 has also brought the need for some companies in the pharma industry to acquire the next size up in building space as they expand their employee headcount.